儿童扁桃体切除术中细胞色素P450药物相互作用的潜在风险
回顾性分析1000例腺扁桃体切除术患儿出院用药,发现3%使用抑制CYP3A4的药物,5%使用抑制CYP2D6的药物,1例使用CYP3A4诱导剂泼尼松,提示部分患儿存在阿片类药物代谢受影响的潜在风险。
要点
- 3%患儿术后使用CYP3A4抑制剂,5%使用CYP2D6抑制剂
- 1例患儿使用CYP3A4诱导剂泼尼松
- OSA患儿对阿片敏感,需考虑药物相互作用
核心结论
- 小部分腺扁桃体切除术患儿使用可能改变阿片类药物代谢的药物,需考虑药物相互作用以决定阿片适用性及剂量。
研究设计与样本
- 回顾性病例系列,纳入1000例在威斯康星儿童医院行腺扁桃体切除术的患儿,审查出院药物核对表。
主要发现
- 术后共使用157种全身吸收药物,8%患儿术后使用至少5种非扁桃体术后药物。
- 最常用5种药物为沙丁胺醇、西替利嗪、氟替卡松鼻喷雾剂、孟鲁司特和聚乙二醇。
- 30例(3%)使用抑制CYP3A4的药物,1例使用CYP3A4诱导剂泼尼松,46例(5%)使用抑制CYP2D6的药物。
关键数值与推荐
- 根据美国FDA发布的CYP诱导剂和抑制剂列表判定潜在相互作用。
临床怎么用
- 对腺扁桃体切除术患儿应审查合并用药,评估CYP相关药物相互作用,尤其OSA患儿使用阿片时需谨慎决定是否用药及剂量。
局限性
- 单中心回顾性研究,仅基于出院药物核对表,未评估实际临床结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the frequency of potential cytochrome P450 (CYP) drug-drug interactions affecting opioid metabolism among children undergoing adenotonsillectomy. STUDY DESIGN: Case series with chart review. SETTING: Tertiary care children's hospital. SUBJECTS AND METHODS: A retrospective review was conducted of 1000 patients undergoing adenotonsillectomy at Children's Hospital of Wisconsin. The discharge medication reconciliation form was reviewed. Each patient's list of medications was compared with various published sources to determine whether medications causing CYP inhibition or induction were present. RESULTS: There were 157 unique medications with systemic absorption given postoperatively to this patient cohort. Eight percent of patients were on at least 5 medications after surgery other than their posttonsillectomy medication. The 5 most commonly prescribed medications were albuterol, cetirizine, fluticasone nasal spray, montelukast, and polyethylene glycol. Per a list of known CYP inducers and inhibitors published by the US Food and Drug Administration, 30 (3%) patients were on a medication that inhibited CYP3A4; 1 patient was on a CYP3A4 inducer, prednisone; and 46 (5%) patients were on a medication that inhibited CYP2D6. CONCLUSIONS: A small fraction of patients undergoing adenotonsillectomy are on medications that potentially alter the metabolism of opioid pain medications. Given the narrow therapeutic index of opioids and increased sensitivity to opioids among patients with obstructive sleep apnea, drug-drug interactions need to be considered as they relate to whether an opioid is appropriate and at what dose.
引用
- Faria J, Solverson M, Faria M, et al. Potential Cytochrome P450 Drug-Drug Interactions among Pediatric Patients Undergoing Tonsillectomy. Otolaryngol Head Neck Surg. 2018. PMID: 30105930. doi:10.1177/0194599818793850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。